Navigation Links
AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity
Date:2/15/2008

appropriate medical attention, yet the AAP continues to dismiss these treatments."

A growing body of scientific research including a Centers for Disease Control study from 2000 indicates a link between thimerosal exposure and several specific neurological injuries including autism. For years, Shreffler and her colleagues have requested the toxins be removed from all vaccines.

"If the AAP truly wants the best possible publicity for vaccines, they can start by discouraging the use of toxic components."

For more information, visit http://www.nationalautism.org.

CONTACT: Wendy Fournier, Portsmouth, RI, 401-835-5828

Rita Shreffler, Nixa, MO, 401-632-6452


'/>"/>
SOURCE National Autism Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
2. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
3. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
4. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
5. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
6. Harbinger Research Initiates Coverage on HearAtLast
7. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
8. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
9. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
10. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
11. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...gs that inhibit estrogen, , , MONDAY, N...breast cancer and osteoporosis eliminated cervical...e drugs also cleared precancerous growths in the c...r in mice with precancerous lesions. , The brea...steoporosis drug raloxifene were given to mice gen...
(Date:11/9/2009)...ally, study finds, , , MONDAY, Nov. 9 (... drug Plavix (clopidogrel) works about the same in...ials has found. , "After this study, I can say ... with this very important drug," said Dr. Jeffrey ...t New York University Langone Medical Center in Ne...
(Date:11/9/2009)...s everybody,s buzz word today and for Recruiters a...es Recruiters and Staffers create their own privat...te and close positions. The site also enables indi...ork with recruiters. , (P...s everyone to network more than ever and by the la...
(Date:11/9/2009)...uld boost self-esteem, researchers say , ...ldren are more likely to have handwriting problems...thout autism, researchers say. , The new study ...udy participants had autism spectrum disorder, but...e for perceptual reasoning on an IQ test. , The...
(Date:11/9/2009)...ned sexual function, study says, , , ...e able to restore sexual function to rabbits with ...e lab and implanting it, a new study reports. ,...hers say the technique could one day be used to tr...ere able to show the tissue was able to integrate ...
Breaking Medicine News(10 mins):Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3
... , THE JOURNAL OF THE AMERICAN SOCIETY OF PLASTIC ... following is being released by the American Socie... Health Care Spending? , A new study suggests that... is not probable. The author, who completed health...
...HAM, Mass., Jan. 5 , , , WHAT: YEAR-IN-P... , , WHEN: Wednesday, January 7, 2009 11:00 AM...son, Co-president, Millennium Research Group , , ...ary webinar identifying the top 10 trends and even...
...ary is National Hot Tea Month, the Height of the C...is National Hot Tea Month and is also the height o...ates that there will be more than 200,000 American...? , , The CDC strongly recommends an annual flu v...
...USTA, Ga. Just days after the first retinal cell ...tiguous cells start committing suicide and researc...er treatment of this potentially blinding infectio... disease process such as diabetes, said Dr. Sally ...
...CETON, N.J., Jan. 5 BullMarket.com ( http://www.b...ocused on long-term growth and income-generating s...verage on several healthcare IT stocks, including ...olutions (Nasdaq: MDRX ), and McKesson (NYSE: ...
...HIRE, Conn., Jan. 5 Alexion Pharmaceuticals, Inc....d Bell, Chief Executive Officer of Alexion Pharmac...n Healthcare Conference in San Francisco at 4:30 p... webcast at: www.alexionpharm.com . An archived v...
Other Medicine News:Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3Health News:Millennium Research Group's Year-in-Preview Webinar 2Health News:Flu Season is Tea Time 2Health News:Cell death from cytomegalovirus may bring new life to treatment of retinal disease 2Health News:BullMarket.com Examines Healthcare IT Stocks 2
(Date:11/9/2009)... -- Women,s sexual health company, TivaMed, today ...prepares for a 2010 launch of its Viveve system to...a name that we believe captures the essence of our...ry Pope, Viveve,s president and chief executive. "...n restore their sense of fulfillment and sexual sa...
(Date:11/9/2009)...- Access MediQuip, LLC, the nation,s first and lar...vice management solutions to the healthcare indust...orate headquarters to Lake Mary, Florida. The mov...includes a major expansion of the Primera Blvd, La...0 and relocation and expansion of the Houston faci...
(Date:11/9/2009)... Decision Resources, one of the world,s leading re...ealthcare issues, finds that, in 2008, human epide...rapies -- which include Roche/Chugai,s Herceptin a...- were the highest-selling drug class in breast ca...Tykerb/Tyverb and the expected launches of three n...
Breaking Medicine Technology:Women's Sexual Health Company Changes Name in Preparation for Market Entry 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Open source DNA 55727 1Open source DNA 55727 1New developments in reproductive medicine 9741 1New developments in reproductive medicine 9741 2
...ve Hemoglobin Receives Rave Reviews from Attendees...Exhibit, IRVINE, Calif., March 6 Masimo, the inv... Motion and Low Perfusion pulse,oximetry, reported...accuracy and clinical effectiveness of the Masimo ... week to over 8,000 anesthesiologists at the 14th,...
...N, March 5 While doctors already,face many challe...egnant,women with the disease, in particular, can ... therapies can harm developing fetuses. According ...e in Blood, the official,journal of the American S...,imatinib, a commonly used therapy for chronic mye...
Other Medicine Technology:New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 2New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 3New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 4New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 5New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 6Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 2Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities 3
Rheumatoid Factor ADVIA 1650
Rheumatoid Factor - Liquid Immunoassay Reagents
ACUVUE OASYS with HYDRACLEAR™ PLUS
C-VUE 55 Toric Multifocal Lens
Medicine Products: